The Experts below are selected from a list of 75240 Experts worldwide ranked by ideXlab platform
Audrey Gordon - One of the best experts on this subject based on the ideXlab platform.
-
the validity and reliability of the violence Risk scale a treatment friendly violence Risk Assessment Tool
Psychology Public Policy and Law, 2006Co-Authors: Stephen C P Wong, Audrey GordonAbstract:The development of Risk Assessment Tools that use dynamic variables to predict recidivism and to inform and facilitate violence reduction interventions is the next major challenge in the field of Risk Assessment and management. This study is the first in a 2-step process to validate the Violence Risk Scale (VRS), a Risk Assessment Tool that integrates violence Assessment, prediction, and treatment. Ratings of the 6 static and 20 dynamic VRS variables assess the client's level of Risk. Ratings of the dynamic variables identify treatment targets linked to violence, and ratings of the stages of change of the treatment targets assess the client's treatment readiness and change. The VRS scores of 918 male offenders showed good interrater reliability and internal consistency and could predict violent and nonviolent recidivism over both short- and longer term (4.4-year) follow-up. The probability of violent and nonviolent recidivism varied linearly with VRS scores. Dynamic and static variables performed equally well. The results support the contention that the VRS can be used to assess violent Risk and to guide violence reduction treatment.
Donald M Lloydjones - One of the best experts on this subject based on the ideXlab platform.
-
a systematic examination of the 2013 acc aha pooled cohort Risk Assessment Tool for atherosclerotic cardiovascular disease
Journal of the American College of Cardiology, 2014Co-Authors: Kunal N Karmali, David C Goff, Hongyan Ning, Donald M LloydjonesAbstract:Abstract Background The 2013 American College of Cardiology/American Heart Association updated cholesterol guidelines recommend the use of Pooled Cohort Equations to estimate 10-year absolute Risk for atherosclerotic cardiovascular disease (ASCVD) in primary prevention. Objectives This study sought to systematically examine the Pooled Cohort Equations to determine Risk factor levels required to exceed Risk thresholds outlined in new cholesterol guidelines. Methods We entered continuous Risk factor levels in isolation and in specified combinations with the Risk Tool, and we observed predicted Risk output patterns. We used the 10-year ASCVD Risk threshold of ≥7.5% as a clinically relevant Risk threshold. Results We demonstrated that a hypothetical man or woman can reach clinically relevant Risk thresholds throughout the eligible age spectrum of 40 to 79 years of age, depending on the associated Risk factor burden in all race-sex groups. Age continues to be a major determinant of 10-year ASCVD Risk for both men and women. Compared with the previous Risk Assessment Tool used in cholesterol guidelines, the inclusion of a stroke endpoint and use of race-specific coefficients permit identification of at-Risk African Americans and non-Hispanic white women at much younger ages and lower Risk factor levels. Conclusions These data provide context of specific Risk factor levels and groups of individuals who are likely to have 10-year ASCVD Risk estimates ≥7.5%. Age continues to be a major driver of Risk, which highlights the importance of the clinician-patient discussion before statin therapy is initiated.
-
who exceeds atp iii Risk thresholds systematic examination of the effect of varying age and Risk factor levels in the atp iii Risk Assessment Tool
Preventive Medicine, 2008Co-Authors: Margaret W Cavanaughhussey, Jarett D Berry, Donald M LloydjonesAbstract:Abstract Objective We sought to determine the levels of Risk factors required to exceed threshold values of intermediate (≥ 10%) or high (> 20%) predicted 10-year Risk for coronary heart disease using the Adult Treatment Panel III (ATP-III) Risk Assessment Tool. Methods Continuous Risk factor values were entered into the Risk Assessment Tool to examine levels of predicted 10-year Risk. Both individual Risk factors and the joint effects of varying multiple Risk factors were systematically examined. Results Women only exceed 10% Risk at ages ≥ 70 with single Risk factors of HDL-cholesterol levels 170 mm Hg. Women ≤ 65 only exceed 10% Risk if they are smokers with low HDL-cholesterol levels. In contrast, single Risk factors can cause men over 45 to exceed 10% or 20% predicted 10-year Risk. Combinations of only modestly elevated Risk factors cause many men to exceed 10% Risk at ages ≥ 45, and to exceed 20% Risk at ages ≥ 55. Conclusions Because such high-Risk factor levels are required for men
Nadia Rosencher - One of the best experts on this subject based on the ideXlab platform.
-
quantification of Risk factors for venous thromboembolism a preliminary study for the development of a Risk Assessment Tool
Haematologica, 2003Co-Authors: Meyer Michel Samama, Ola E Dahl, Daniel J Quinlan, Patrick Mismetti, Nadia RosencherAbstract:BACKGROUND AND OBJECTIVES: Venous thromboembolism is a frequent and serious disorder influenced by numerous factors. As the first step in creating a Tool to assess an individual patient's Risk of venous thromboembolism, we carried out a literature review in order to quantify Risk factors for venous thromboembolism. EVIDENCE AND INFORMATION SOURCES: Risk factors were identified as being either predisposing, that is, those Risks presented by a patient prior to hospital admission, or exposing, that is, those Risks occurring when a patient is hospitalized for a certain medical condition or surgical procedure. Predisposing Risk factors were classified with regard to the patients' characteristics (including general characteristics and inherent Risk factors), and recent and chronic clinical conditions. RESULTS: The major predisposing factors among the patients' characteristics were age, hormonal therapy and personal history of venous thromboembolism, along with inherited coagulation factor abnormalities. Clinical situations associated with the highest Risk of venous thromboembolism were recent surgery, hospitalization for medical conditions and immobilization, moderate to severe congestive heart failure, and malignancy. CONCLUSIONS: This literature review will assist in the development of a suitable Risk Assessment Tool for aiding healthcare professionals to decide whether to employ thromboprophylaxis, and, if so, to select the appropriate type and duration of prophylaxis.
William D. Leslie - One of the best experts on this subject based on the ideXlab platform.
-
the fracture Risk Assessment Tool frax predicts fracture Risk in patients with chronic kidney disease
Kidney International, 2019Co-Authors: William D. Leslie, Reid Whitlock, James Shaw, Claudio Rigatto, Laurel Thorlacius, Paul Komenda, David CollisterAbstract:The Fracture Risk Assessment Tool (FRAX®) was developed to predict fracture Risk in the general population, but its applicability to patients with chronic kidney disease (CKD) is unknown. Using the Manitoba Bone Mineral Density (BMD) Database, we identified adults not receiving dialysis with available serum creatinine measurements and bone densitometry within 1 year. Estimated glomerular filtration rate (eGFR) was calculated using the Chronic Kidney Disease Epidemiology Collaboration equation. Incident major osteoporotic fractures and hip fractures were ascertained from population-based health care databases. The performance of FRAX, derived without and with BMD, was studied in relation to CKD stage. Among 10,099 subjects (mean age 64 ± 13 years, 13.0% male), 2,154 had eGFR 30-60 mL/min/1.73 m2 (CKD stage 3) and 590 had eGFR
-
construction and validation of a simplified fracture Risk Assessment Tool for canadian women and men results from the camos and manitoba cohorts
Osteoporosis International, 2011Co-Authors: Jonathan D Adachi, Claudie Berger, William D. Leslie, Lisa Langsetmo, David A Hanley, George Ioannidis, Robert G Josse, Christopher S Kovacs, Tanveer TowheedAbstract:Summary A procedure for creating a simplified version of fracture Risk Assessment Tool (FRAX®) is described. Calibration, fracture prediction, and concordance were compared with the full FRAX Tool using two large, complementary Canadian datasets.
Stephen C P Wong - One of the best experts on this subject based on the ideXlab platform.
-
the validity and reliability of the violence Risk scale a treatment friendly violence Risk Assessment Tool
Psychology Public Policy and Law, 2006Co-Authors: Stephen C P Wong, Audrey GordonAbstract:The development of Risk Assessment Tools that use dynamic variables to predict recidivism and to inform and facilitate violence reduction interventions is the next major challenge in the field of Risk Assessment and management. This study is the first in a 2-step process to validate the Violence Risk Scale (VRS), a Risk Assessment Tool that integrates violence Assessment, prediction, and treatment. Ratings of the 6 static and 20 dynamic VRS variables assess the client's level of Risk. Ratings of the dynamic variables identify treatment targets linked to violence, and ratings of the stages of change of the treatment targets assess the client's treatment readiness and change. The VRS scores of 918 male offenders showed good interrater reliability and internal consistency and could predict violent and nonviolent recidivism over both short- and longer term (4.4-year) follow-up. The probability of violent and nonviolent recidivism varied linearly with VRS scores. Dynamic and static variables performed equally well. The results support the contention that the VRS can be used to assess violent Risk and to guide violence reduction treatment.
